Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy

A. Nozdricheva, I. Lysenko, N. Guskova, N. Nikolaeva, Y. Gaysultanova, S. Dimitriadi, O. G. Ishonina
{"title":"Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy","authors":"A. Nozdricheva, I. Lysenko, N. Guskova, N. Nikolaeva, Y. Gaysultanova, S. Dimitriadi, O. G. Ishonina","doi":"10.17650/1818-8346-2024-19-2-67-74","DOIUrl":null,"url":null,"abstract":"Aim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Materials and methods. The open longitudinal study included 39 patients with newly diagnosed diffuse large B-cell lymphoma who received specialized treatment at the Oncohematology Department of National Medical Research Centre for Oncology (Rostov-on-Don) in 2021. Patients received induction immunochemotherapy according to the R-CHOP regimen (rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone) in combination with accompanying therapy (allopurinol 300 mg/day). Blood sampling was carried out at 0, 24, 48, 72, 120 hours and on 21st day of the 1st therapy cycle. Patients were divided into 2 groups depending on the GFR level, calculated by creatinine, before treatment: group A – 27 (69 %) patients with GFR >90 ml/min/1.73 m2, group B – 12 (31 %) patients with GFR <90 ml/min/1.73 m2.Results. During the immunochemotherapy in patients with initially reduced GFR, a further decrease was observed with the restoration of the initial level by day 21 of therapy. When calculating GFR by cystatin C, in contrast to the calculation by creatinine, it revealed the dependence of GFR level on pathological process stage: GFR in group A patients with stages I–II is 20.4 % lower than in patients with stages III–IV, in group B – by 30.5 %. The use of the fisher test at GFR thresholds of 90 and 60 ml/min/1.73 m2 revealed a greater advantage in establishing absolute GFR levels, especially in the range of 60 to 90 ml/min/1.73 m2.Conclusion. The data obtained confirm that the determination of GFR by cystatin C in patients with diffuse large B-cell lymphoma is a more sensitive method that objectively reflects the functional state of the kidneys, especially when values are within the “gray area” – from 90 to 60 ml/min/1.73 m2.","PeriodicalId":518071,"journal":{"name":"Oncohematology","volume":"140 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncohematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1818-8346-2024-19-2-67-74","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Materials and methods. The open longitudinal study included 39 patients with newly diagnosed diffuse large B-cell lymphoma who received specialized treatment at the Oncohematology Department of National Medical Research Centre for Oncology (Rostov-on-Don) in 2021. Patients received induction immunochemotherapy according to the R-CHOP regimen (rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone) in combination with accompanying therapy (allopurinol 300 mg/day). Blood sampling was carried out at 0, 24, 48, 72, 120 hours and on 21st day of the 1st therapy cycle. Patients were divided into 2 groups depending on the GFR level, calculated by creatinine, before treatment: group A – 27 (69 %) patients with GFR >90 ml/min/1.73 m2, group B – 12 (31 %) patients with GFR <90 ml/min/1.73 m2.Results. During the immunochemotherapy in patients with initially reduced GFR, a further decrease was observed with the restoration of the initial level by day 21 of therapy. When calculating GFR by cystatin C, in contrast to the calculation by creatinine, it revealed the dependence of GFR level on pathological process stage: GFR in group A patients with stages I–II is 20.4 % lower than in patients with stages III–IV, in group B – by 30.5 %. The use of the fisher test at GFR thresholds of 90 and 60 ml/min/1.73 m2 revealed a greater advantage in establishing absolute GFR levels, especially in the range of 60 to 90 ml/min/1.73 m2.Conclusion. The data obtained confirm that the determination of GFR by cystatin C in patients with diffuse large B-cell lymphoma is a more sensitive method that objectively reflects the functional state of the kidneys, especially when values are within the “gray area” – from 90 to 60 ml/min/1.73 m2.
弥漫大 B 细胞淋巴瘤患者在诱导免疫化疗期间肾小球滤过率评估方法的客观化
目的研究新诊断弥漫大B细胞淋巴瘤患者在诱导免疫化疗期间通过肌酐和胱抑素C计算的肾小球滤过率(GFR)动态变化,以确定客观的估算方法。这项开放式纵向研究纳入了 39 名新确诊的弥漫大 B 细胞淋巴瘤患者,他们于 2021 年在国立肿瘤医学研究中心(顿河畔罗斯托夫)肿瘤血液学部接受了专业治疗。患者根据R-CHOP方案(利妥昔单抗、多柔比星、环磷酰胺、长春新碱和泼尼松龙)接受了诱导免疫化疗,并同时接受了辅助治疗(别嘌呤醇300毫克/天)。在第一个治疗周期的 0、24、48、72、120 小时和第 21 天进行抽血。根据治疗前肌酐计算的肾小球滤过率水平,患者被分为两组:A 组--27 名(69%)肾小球滤过率大于 90 毫升/分钟/1.73 平方米的患者;B 组--12 名(31%)肾小球滤过率小于 90 毫升/分钟/1.73 平方米的患者。在免疫化疗期间,最初 GFR 降低的患者的 GFR 进一步降低,在治疗第 21 天时恢复到最初水平。用胱抑素 C 计算肾小球滤过率与用肌酐计算肾小球滤过率不同,它揭示了肾小球滤过率水平与病理过程分期的关系:A 组 I-II 期患者的 GFR 比 III-IV 期患者低 20.4%,B 组低 30.5%。在 90 毫升/分钟/1.73 平方米的 GFR 临界值和 60 毫升/分钟/1.73 平方米的 GFR 临界值上使用 Fisher 试验,在确定 GFR 绝对水平方面具有更大的优势,尤其是在 60 至 90 毫升/分钟/1.73 平方米的范围内。所获得的数据证实,用胱抑素 C 测定弥漫大 B 细胞淋巴瘤患者的 GFR 是一种更灵敏的方法,能客观地反映肾脏的功能状态,尤其是当数值处于 90 至 60 毫升/分钟/1.73 平方米的 "灰色区域 "时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信